Background: Tuberculosis (TB) is a major threat to public health, particularly in countries where the disease is highly prevalent, such as Ethiopia. Early diagnosis and treatment are the main components of TB prevention and control. Although the national TB guideline recommends the primary use of rapid TB diagnostics whenever feasible, there is limited evidence available that assess the efficiency of deploying various diagnostic tools in the country. Hence, this study aims to evaluate the cost-effectiveness of rapid TB/MDR-TB diagnostic tools in Ethiopia.

Methods: A hybrid Markov model for a hypothetical adult cohort of presumptive TB cases was constructed. The following TB diagnostic tools were evaluated: X-pert MTB/RIF, Truenat, chest X-ray screening followed by an X-pert MTB/RIF, TB-LAMP, and smear microscopy. Cost-effectiveness was determined based on incremental costs ($) per Disability-adjusted Life Years (DALY) averted, using a threshold of one times Gross Domestic Product (GDP) per capita ($856). Data on starting and transition probabilities, costs, and health state utilities were derived from secondary sources. The analysis is conducted from the health system perspective, and a probabilistic sensitivity analysis is performed.

Result: The incremental cost-effectiveness ratio for X-pert MTB/RIF, compared to the next best alternative, is $276 per DALY averted, making it a highly cost-effective diagnostic tool. Additionally, chest X-ray screening followed an X-pert MTB/RIF test is less cost-effective, with an ICER of $1666 per DALY averted. Introducing X-pert MTB/RIF testing would enhance TB detection and prevent 9600 DALYs in a cohort of 10,000 TB patients, with a total cost of $3,816,000.

Conclusion: The X-pert MTB/RIF test is the most cost-effective diagnostic tool compared to other alternatives. The use of this diagnostic tool improves the early detection and treatment of TB cases. Increased funding for this diagnostic tool will enhance access, reduce the TB detection gaps, and improve treatment outcomes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11106958PMC
http://dx.doi.org/10.1186/s12962-024-00544-1DOI Listing

Publication Analysis

Top Keywords

x-pert mtb/rif
24
diagnostic tool
16
diagnostic tools
12
daly averted
12
chest x-ray
8
x-ray screening
8
screening x-pert
8
cost-effective diagnostic
8
mtb/rif test
8
test cost-effective
8

Similar Publications

Article Synopsis
  • A study was conducted to analyze the causes of pneumonia in both HIV-infected and HIV-uninfected patients using advanced testing methods on bronchoalveolar lavage fluid (BALF).
  • The study involved 141 HIV-infected and 104 HIV-uninfected patients from January 2022 to May 2024, focusing on identifying various pathogens and assessing clinical data such as CD4 T-cell counts and treatment status.
  • Results showed that HIV-uninfected patients were generally older and had more comorbidities, whereas HIV-infected patients had a higher prevalence of mixed-pathogen infections but lower TB detection rates; overall, the findings emphasized the importance of using mNGS and X-pert tests for timely pathogen identification in
View Article and Find Full Text PDF

Background: Tuberculosis (TB) is a major public health concern in the developing countries. Moreover, the emergence of multidrug-resistant tuberculosis is challenging. However, there are no organized data on the trends of pulmonary tuberculosis and rifampicin-resistant Mycobacterium tuberculosis in the study area.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effectiveness of metagenomic next-generation sequencing (mNGS) for diagnosing pathogens in community-acquired pneumonia (CAP) by analyzing 555 bronchoalveolar lavage fluid samples from 541 patients.
  • Results show that mNGS has a significantly higher positivity rate (79.1%) compared to sputum culture (11.4%), highlighting its potential for better pathogen detection.
  • While mNGS is effective for identifying various pathogens, it is less sensitive for detecting active tuberculosis compared to the X-pert MTB/RIF test (64.6% vs. 85.4%).
View Article and Find Full Text PDF

Background: Tuberculosis (TB) is a major threat to public health, particularly in countries where the disease is highly prevalent, such as Ethiopia. Early diagnosis and treatment are the main components of TB prevention and control. Although the national TB guideline recommends the primary use of rapid TB diagnostics whenever feasible, there is limited evidence available that assess the efficiency of deploying various diagnostic tools in the country.

View Article and Find Full Text PDF

Prevalence of Rifampicin resistance tuberculosis among presumptive tuberculosis patients in Egypt-2021: a national health facility-based survey.

BMC Infect Dis

February 2024

Community, Environmental and Occupational medicine department, Faculty of Medicine-Ain, Shams University, Cairo, Egypt.

Background: The magnitude of MDR-TB cases was noticeable in Egypt. However, the last national survey was 11-years ago. The current survey was conducted to determine the prevalence of rifampicin resistance among sputum smear-positive pulmonary tuberculosis patients in Egypt.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!